VA
MRK icon

Vident Advisory’s Merck MRK Stock Holding History

Vident Advisory’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.8M Buy
139,324
+10,064
+8% +$1.16M 0.14% 126
2025
Q4 		$13.6M Buy
129,260
+9,578
+8% +$899K 0.12% 147
2025
Q3 		$10M Sell
119,682
-17,614
-13% -$1.45M 0.1% 194
2025
Q2 		$10.9M Buy
137,296
+5,318
+4% +$423K 0.12% 155
2025
Q1 		$11.8M Sell
131,978
-22,859
-15% -$2.13M 0.17% 114
2024
Q4 		$15.4M Sell
154,837
-69,345
-31% -$7.15M 0.27% 81
2024
Q3 		$25.5M Buy
224,182
+75,350
+51% +$8.95M 0.64% 25
2024
Q2 		$18.4M Buy
148,832
+3,028
+2% +$390K 0.51% 34
2024
Q1 		$19.2M Sell
145,804
-28,830
-17% -$3.55M 0.4% 61
2023
Q4 		$19M Sell
174,634
-551
-0.3% -$57.2K 0.48% 39
2023
Q3 		$18M Buy
+175,185
New +$18.9M 0.56% 31

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vident Advisory's MRK Position: Q1 2026 in Review

Vident Advisory increased its Merck (MRK) stake by 7.8% in Q1 2026, buying an estimated $1.16M and bringing the position to 139,324 shares worth $16.8M. The position accounts for 0.14% of the portfolio, ranked #126.

Vident Advisory first reported a position in MRK in Q3 2023 and has held it in 11 quarters since. The position peaked at $25.5M in Q3 2024. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Vident Advisory held 139,324 shares of Merck worth $16.8M as of Q1 2026.
  • Vident Advisory bought 10,064 Merck shares in Q1 2026, an estimated $1.16M.
  • Merck made up 0.14% of Vident Advisory's portfolio in Q1 2026, its #126 holding.
  • Vident Advisory first reported a position in Merck in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Merck position peaked at $25.5M in Q3 2024.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.